• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

TriSalus names new chief medical officer

September 29, 2020 By Danielle Kirsh

TriSalus-logoTriSalus today said it appointed Steven Katz as chief medical officer.

Katz will be responsible for overseeing the company’s clinical development strategy in the treatment of solid tumors. He has served as TriSalus’s chief medical advisor and chairperson of its scientific advisory board since 2018.

“We are thrilled to have Steven join TriSalus as a member of our leadership team and one who will advance our goal of improving outcomes for patients with solid pancreatic and liver tumors,” president and CEO Mary Szela said in a news release. “Steven’s scientific acumen and clinical experience are second to none, but it’s his relentless commitment to eradicating solid tumors by embracing new approaches that will make the most lasting impact on overcoming one of the greatest challenges in cancer care.”

Prior to joining the company, Katz completed fellowships in immunology and surgical oncology at the Memorial Sloan-Kettering Cancer Center in New York, where he also served as the chief administrative fellow. He has also been the principal investigator for five solid tumor CAR-T trials and has invented numerous cell therapy products and methods currently under testing or development, according to TriSalus.

“Joining TriSalus will allow me to leverage my experiences as a surgeon, clinician and scientist to realize my ultimate goal – transforming outcomes for solid tumor patients with metastatic disease. New therapies are improving the way in which we treat cancer, but critical barriers in solid tumors prevent optimal delivery and performance of therapeutics,” Katz said. “I can’t wait to continue our work as a member of the TriSalus team. We’re focused on integrating delivery technology that can deliver therapeutic directly to the site of disease with therapeutic agents that both kill cancer cells and stimulate the body’s immune system in the fight. Through our relationships with exceptional academic clinical sites, we can rapidly initiate and execute clinical trials using this novel approach.”

Filed Under: Clinical Trials, Oncology, Personnel Tagged With: trisaluslifesciences

IN CASE YOU MISSED IT

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS